Home › Funds › TANG CAPITAL MANAGEMENT LLC › KNSA

TANG CAPITAL MANAGEMENT LLC position in KNSA

KINIKSA PHARMACEUTICALS INTL · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 2,259,889 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q2 2026 13F filing — a position valued at US$144.5M, representing 6.56% of its reported portfolio and ranking #4 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed KNSA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.26M sh
Reported value held$144.52M
Portfolio Weight6.56%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's KNSA position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in KNSA in Q3 2023 at 600,000 shares (US$10.4M). The position peaked in Q2 2026 at 2,259,889 shares, worth US$144.5M. Across 12 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 2,259,889 shares valued at US$144.5M. Notable position changes include a 25% increase in Q2 2024 (shares rose 34% over the following quarter), a 237% increase in Q1 2025 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 600.00K $10.42M New
Q4 2023 600.00K $10.52M Hold
Q1 2024 500.00K $9.87M Reduce
Q2 2024 625.31K $11.67M Add
Q3 2024 628.61K $15.71M Add
Q4 2024 628.61K $12.43M Hold
Q1 2025 2.12M $47.05M Add
Q2 2025 2.33M $64.43M Add
Q3 2025 2.33M $90.42M Hold
Q4 2025 2.26M $93.22M Reduce
Q1 2026 2.26M $108.81M Hold
Q2 2026 2.26M $144.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 48 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), Spruce Street Capital LP (US$58.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held KNSA?

TANG CAPITAL MANAGEMENT LLC has disclosed KNSA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in KNSA?

As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 2.26M shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $144.52M, representing 6.56% of its reported portfolio and ranking #4.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling KNSA?

In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in KNSA. The position peaked in Q2 2026 at 2.26M shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, Spruce Street Capital LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.